US 9556130
4-oxo-3,4-dihydro-1,2,3-benzotriazine modulators of GPR139
granted A61KA61K31/53A61P
Quick answer
US patent 9556130 (4-oxo-3,4-dihydro-1,2,3-benzotriazine modulators of GPR139) held by Takeda Pharmaceutical Company Limited expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/53, A61P, A61P21/00, A61P25/00